Amphetamines for Adult ADHD (Vyvanse®, Adderall®): What Does the Best Science Say?

Attention Deficit Hyperactivity Disorder (ADHD) doesn’t simply disappear when adulthood begins. For many, challenges with focus, impulsivity, and disorganization persist, affecting careers, studies, and relationships.

As a result, the search for effective Attention Deficit Hyperactivity Disorder  treatment continues, and amphetamine-based medications remain among the most prescribed and recognized options. Names like Vyvanse® (lisdexamfetamine), Adderall® (mixed amphetamine salts – MAS), and other forms of dextroamphetamine are common in adult ADHD management.

But with so much information—and misinformation—circulating, what does high-quality science truly say about the effectiveness and safety of these ADHD stimulants?

To answer this, researchers conducted a Cochrane Systematic Review—a gold standard in scientific evidence, known for rigorously analyzing data from multiple well-designed randomized clinical trials. This review examined 19 studies comparing various types of ADHD amphetamines to placebo in over 2,500 adults.

Anxiety: The Silent Epidemic of the 21st Century by Augusto Cury, PhD

Confira este produto especial!

Buy here, now!!!

What Are the Amphetamines Used for ADHD?

These are stimulant medications that work by increasing the availability of key neurotransmitters like dopamine and norepinephrine in the brain. This action is believed to enhance attention, impulse control, and reduce hyperactivity, positively impacting executive function in adults with Attention Deficit Hyperactivity Disorder . The review included:

• Dextroamphetamine: A specific type of amphetamine.

• Lisdexamfetamine (e.g., Vyvanse®): A prodrug that converts into dextroamphetamine in the body, typically offering extended-release action.

• Mixed Amphetamine Salts (MAS) (e.g., Adderall®): A combination of different amphetamine salts, available in immediate or extended-release formulations.

Also read: ADHD and the Art of Thinking Fast and Slow

Do They Work to Reduce ADHD Symptoms in Adults? (Amphetamine Effectiveness)

The short answer: Yes, in the short term—but with important reservations about evidence quality.

• Symptom Improvement: The review found that amphetamines, particularly lisdexamfetamine and MAS, were more effective than placebo in reducing ADHD symptom severity, according to both clinicians and patients. Lisdexamfetamine showed clear benefits for adult Attention Deficit Hyperactivity Disorder . However, evidence for dextroamphetamine alone was less convincing in clinician assessments, raising questions when comparing lisdexamfetamine to dextroamphetamine.

• Evidence Quality: It’s crucial to highlight that the authors rated the overall evidence as low to very low.
  Why? Mainly due to challenges in maintaining blinding (patients and doctors might guess who’s on active medication due to noticeable stimulant effects), high dropout rates, and short study durations (averaging just 5 weeks). These factors limit conclusions about long-term safety.

Also read: ADHD and the Art of Thinking Fast and Slow

What About Staying on Treatment (Adherence/Retention)?

The findings here were less encouraging. Amphetamines did not show improved treatment retention compared to placebo—meaning patients were no more likely to stay on medication over time.

Are They Safe? Risks and Benefits of Amphetamines for ADHD

Safety remains a key concern with ADHD stimulants. The review highlighted:

• Higher Dropout Rates Due to Side Effects: Adults taking amphetamines were more likely to discontinue treatment because of adverse effects.

• Common Side Effects: Although not detailed extensively, typical amphetamine side effects include insomnia, appetite loss, dry mouth, anxiety, irritability, headaches, nausea, elevated blood pressure, and increased heart rate.

• Cardiovascular Risk: The review found no significant difference between amphetamines and placebo regarding cardiovascular-related dropouts. However, due to short-term data and low-quality evidence, long-term risks remain uncertain.

Also read: ADHD and the Art of Thinking Fast and Slow

Other Key Findings from the Cochrane Review on ADHD and Amphetamines

• Dosage: Higher doses did not prove to be more effective.

• Release Type: No clear differences were found between immediate and extended-release formulations regarding efficacy or safety.

• Comorbidities: The presence of mild anxiety, depression, or substance abuse history didn’t significantly alter amphetamine effectiveness in the limited studies available. However, more research is needed, especially for adults with complex comorbidities.

• Comparison to Other Medications: Few studies compared amphetamines to alternatives like guanfacine, modafinil, or paroxetine—insufficient data to draw conclusions.

• Anxiety and Depression: It remains unclear how amphetamines impact anxiety or depressive symptoms, as most studies excluded patients with severe comorbid conditions.

Also read: ADHD and the Art of Thinking Fast and Slow

Conclusion: Amphetamines Can Help, But Require Caution and Open Discussion

This Cochrane systematic review confirms that stimulants like Vyvanse® and Adderall® can reduce Attention Deficit Hyperactivity Disorder symptoms in adults over the short term. However, this benefit comes with a higher risk of side effects, increased treatment dropout rates, and no guarantee of long-term adherence.

Moreover, the overall quality of research is still considered low, mainly due to short study durations. Long-term effects, especially in individuals with complex comorbidities, remain poorly understood.

What Should You Do With This Information?

• Have an Open Conversation with Your Doctor: ADHD treatment with amphetamines should be personalized, carefully weighing benefits against potential risks and side effects.

• Consider All Options: Amphetamines are one tool among many. Discuss other ADHD medications (like methylphenidate or non-stimulants), therapy (such as CBT), and lifestyle adjustments.

• Monitor Your Response: If starting treatment, stay attentive to how you feel and communicate regularly with your healthcare provider.

• Set Realistic Expectations: Medication is helpful but works best as part of a comprehensive ADHD management plan.

Amphetamines can be valuable for many adults with Attention Deficit Hyperactivity Disorder , but informed decisions—grounded in science and guided by professional advice—are essential.

Important: This content is informational and based on scientific review. Never start, stop, or change your medication without medical guidance.

Also read: ADHD and the Art of Thinking Fast and Slow

Bobbie Goods

Bobbie Goods Postcard Coloring Book combines creativity and connection in a delightful collection of pullout postcards.

Buy here, now!!!

Jeferson Manini

I am Jeferson Magno Amorim Manini, a Psychology undergraduate student with a passion for neuroscience, research, and knowledge. My academic and professional journey has led me to deeply explore Attention Deficit Hyperactivity Disorder (ADHD), not only as a topic of study but as a reality that impacts millions of people.
It was from this passion that TDAH.World was born – a space created to inform, support, and connect people with ADHD. My goal is to translate complex information into accessible content, without losing scientific depth, so that more people can better understand and deal with the challenges – and also the potential – of ADHD.
I believe that well-applied knowledge can transform lives, and that’s what motivates me to keep studying, writing, and sharing insights on neuroscience, mental health, and cognitive performance. If you’ve made it this far, I hope you find something here that makes sense to you!